In a strategic move to improve stroke care in India, Boehringer Ingelheim India has partnered with RED.Health to bolster pre-hospital emergency stroke services. The collaboration, initiated under Boehringer Ingelheim’s Angels Initiative, was formalized through a Memorandum of Understanding (MoU) signed ahead of World Stroke Day. This alliance underscores a shared commitment to enhancing timely, life-saving interventions and transforming the stroke care ecosystem in India.
India is witnessing an alarming rise in stroke cases, with the condition now ranking as the fourth leading cause of death and the fifth leading cause of disability. Many patients fail to reach hospitals within the critical "golden period" of 4.5 hours after symptom onset, drastically reducing their chances of effective treatment. The partnership focuses on bridging this gap through faster response times, specialized training, and advanced medical protocols for pre-hospital care.
“We believe organized, timely intervention can transform stroke outcomes. This collaboration with RED.Health strengthens emergency stroke care and ensures patients receive rapid, high-quality assistance,” stated Gagandeep Singh Bedi, Managing Director of Boehringer Ingelheim India.
Prabhdeep Singh, Founder and CEO of RED.Health, emphasized, “Stroke affects over 1.9 million people in India annually. This MoU empowers our emergency teams with advanced training and protocols, reaffirming our dedication to saving lives and improving outcomes.”
Key components of the MoU include implementing formal stroke protocols in RED.Health ambulances and training emergency responders in stroke-specific scales like FAST (Face, Arm, Speech, Time). These initiatives will be supported by the Angels Initiative at no cost to RED.Health, providing access to advanced stroke life support certification programs and enhancing emergency response capabilities.
This partnership marks a pivotal step in redefining emergency stroke care and ensuring timely medical interventions for communities across India.